New Regulations for medical devices adopted by European Commission on September 26th
Following the PIP scandal concerning breast implants, Commissioner Dalli of the European Commission took the initiative of a resolution.
This resolution was passed in the European Parliament plenary session of this June 14th.
On this basis, a recommendation and a regulation are being drafted by Commission experts. This recommendation and this Regulation should be approved in late 2012 for entry into force early 2013.
They would imply
- Increased surveillance of notified bodies with a revision of the scope of their notification in accordance with their internal skills. That could to imply that some manufacturers will be forced to change their notified bodies because their bodies would no longer be authorized to issue certificates for their type of medical device.
- The establishment of unannounced inspection visit by your notified body. It should be required to pay an additional unannounced visit at each manufacturer by period of 3 years.
Françoise Schlemmer
So that you remained informed about the statutory news concerning your sector and last news in management of the quality, QuasysConsult invites you to consult quarterly your new newsletter
download (only available in french)
The symbol for medical devices containing phthalates is approved with the aim of its publication.
